首页> 美国卫生研究院文献>Molecular and Cellular Therapies >Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre-and post- HAART show immune activation and inflammation the main drivers of host gene expression
【2h】

Genome-wide analysis of primary peripheral blood mononuclear cells from HIV + patients-pre-and post- HAART show immune activation and inflammation the main drivers of host gene expression

机译:全基因组分析HIVHA和HIV患者在HAART前后对原发性外周血单个核细胞的分析表明免疫激活和炎症是宿主基因表达的主要驱动力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlthough the host gene expression in the context of HIV has been explored by several studies, it remains unclear how HIV is able to manipulate and subvert host gene machinery before and after highly active antiretroviral therapy (HAART) in the same individual. In order to define the underlying pharmaco-genomic basis of HIV control during HAART and genomic basis of immune deterioration prior to HAART initiation, we performed a genome-wide expression analysis using primary peripheral blood mononuclear cells (PBMC) derived from 14 HIV + subjects pre-highly active antiretroviral therapy (HAART) (time point-1 or TP1) with detectable plasma viremia and post-HAART (time point-2 or TP2) with effective control of plasma viremia (<40 HIV RNA copies/mL of plasma).
机译:背景技术尽管已经通过多项研究探讨了在HIV环境中的宿主基因表达,但仍不清楚在同一个人中,HIV在高活性抗逆转录病毒治疗(HAART)之前和之后如何能够操纵和破坏宿主基因机制。为了确定HAART过程中HIV控制的基础药物基因组学基础和HAART启动前免疫恶化的基因组基础,我们使用来源于14个HIV +对象的外周血单核细胞(PBMC)进行了全基因组表达分析-可检测血浆病毒血症的高效抗逆转录病毒疗法(HAART)(时间点1或TP1),有效控制血浆病毒血症(<40 HIV RNA拷贝/ mL血浆)的HAART后(时间点2或TP2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号